alanine racemase inhibitors (L2 Diagnostics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namealanine racemase inhibitors (L2 Diagnostics)
Drug Alias NameD-alanine pathway modulators (L2 Diagnostics)L2-04 (L2 Diagnostics)L2-10L2-12L2-16 +[8] 
ClassificationSmall molecules
Mechanisms of ActionAlanine racemase inhibitorsBacterial cell wall synthesis inhibitors
TargetsAlanine racemase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesL2 Diagnostics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesL2 Diagnostics LLC
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A